InvestorsHub Logo
Followers 70
Posts 11376
Boards Moderated 0
Alias Born 01/05/2018

Re: None

Thursday, 08/04/2022 4:12:30 PM

Thursday, August 04, 2022 4:12:30 PM

Post# of 403025
What I cannot understand for the life of me is this one simple question:

Why on earth did Leo not perform the Payer Analysis after the Phase II Clinical Trial of Brilacidin for OM use was completed????

I mean come on - Back in May 2019, Leo supposedly had a meeting with the FDA to review the Clinical Phase III trial plan for Brilacidin use against OM, so why wait 3 years to perform a Payer Analysis????


https://www.otcmarkets.com/stock/IPIX/news/Innovation-Pharmaceuticals-Receives-FDA-End-of-Phase-2-Meeting-Minutes?id=226649
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News